[go: up one dir, main page]

NO895338L - Fremgangsmaate og terapeutiske preparater for forhindring av fibrinavsetning eller adhesjoner. - Google Patents

Fremgangsmaate og terapeutiske preparater for forhindring av fibrinavsetning eller adhesjoner.

Info

Publication number
NO895338L
NO895338L NO89895338A NO895338A NO895338L NO 895338 L NO895338 L NO 895338L NO 89895338 A NO89895338 A NO 89895338A NO 895338 A NO895338 A NO 895338A NO 895338 L NO895338 L NO 895338L
Authority
NO
Norway
Prior art keywords
adhesions
prevention
procedure
therapeutic preparations
fibrin deposit
Prior art date
Application number
NO89895338A
Other languages
English (en)
Other versions
NO301748B1 (no
NO895338D0 (no
Inventor
Marjorie A Mohler
Tue H Nguyen
Original Assignee
Genentech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech Inc filed Critical Genentech Inc
Publication of NO895338D0 publication Critical patent/NO895338D0/no
Publication of NO895338L publication Critical patent/NO895338L/no
Publication of NO301748B1 publication Critical patent/NO301748B1/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49Urokinase; Tissue plasminogen activator
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO895338A 1987-07-01 1989-12-29 Fremgangsmåte for fremstilling av et farmasöytisk preparat for forhindring av fibrinavsetning eller adhesjonsdannelse eller -nydannelse NO301748B1 (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US6887287A 1987-07-01 1987-07-01
US12531987A 1987-11-25 1987-11-25
US21089588A 1988-06-24 1988-06-24
PCT/US1988/002194 WO1989000049A1 (en) 1987-07-01 1988-06-30 Method and therapeutic compositions for the prevention of fibrin deposition or adhesions

Publications (3)

Publication Number Publication Date
NO895338D0 NO895338D0 (no) 1989-12-29
NO895338L true NO895338L (no) 1990-02-28
NO301748B1 NO301748B1 (no) 1997-12-08

Family

ID=27371438

Family Applications (1)

Application Number Title Priority Date Filing Date
NO895338A NO301748B1 (no) 1987-07-01 1989-12-29 Fremgangsmåte for fremstilling av et farmasöytisk preparat for forhindring av fibrinavsetning eller adhesjonsdannelse eller -nydannelse

Country Status (14)

Country Link
EP (1) EP0297860B1 (no)
JP (1) JP2756131B2 (no)
KR (1) KR0131330B1 (no)
AU (1) AU621305B2 (no)
DE (1) DE3883645T2 (no)
DK (1) DK175597B1 (no)
FI (1) FI103868B (no)
IE (1) IE65658B1 (no)
IL (2) IL86933A (no)
NO (1) NO301748B1 (no)
NZ (1) NZ225260A (no)
PH (1) PH26527A (no)
PT (1) PT87886B (no)
WO (1) WO1989000049A1 (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3741149A1 (de) * 1987-12-04 1989-06-15 Thomae Gmbh Dr K Zubereitungsformen zur verhinderung von adhaesionen von organen und organteilen
US5364622A (en) * 1987-12-04 1994-11-15 Dr. Karl Thomae Gmbh Methods for preventing adhesions to organs and parts of organs by application of tissue plasminogen activator and hydroxyethylcellulose hydrogel
CA1340994C (en) * 1989-09-21 2000-05-16 Rudolf Edgar Dr. Falk Treatment of conditions and disease
WO1995001292A1 (en) * 1993-07-02 1995-01-12 Quest International Bv. Packaging of enzymes
US5869810A (en) * 1995-05-23 1999-02-09 Victor Reynolds Impedance-heated furnace
DE19529223A1 (de) * 1995-08-09 1997-02-13 Boehringer Mannheim Gmbh Verwendung von Plasminogenaktivatoren zum lokalen Knochenaufbau
US5837688A (en) * 1996-11-27 1998-11-17 Gelfand; Mathew I. Use of thrombolytic reagents for prevention of vascular disease
US7067485B2 (en) 1997-11-07 2006-06-27 Chiron Corporation IGF-I composition and its use
EP1028747A1 (en) * 1997-11-07 2000-08-23 Chiron Corporation Novel igf-i composition and its use
FR2918276B1 (fr) * 2007-07-02 2010-01-22 Anteis Sa "utilisation d'un gel de polysaccharide(s)naturel(s)pour la preparation d'une formulation injectable de traitement des degenerescences articulaires"
DE102014112212A1 (de) 2014-08-26 2016-03-03 Akesion Gmbh Rekombinante Fusionsproteine zur Vorbeugung oder Behandlung von Adhäsionen bei Geweben oder Organen

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1229075B (it) * 1985-04-05 1991-07-17 Fidia Farmaceutici Medicamenti per uso topico, ottenuti tramite l'impiego dell'acido ialuronico
DE3500268A1 (de) * 1985-01-05 1986-07-10 Hoechst Ag, 6230 Frankfurt Praeparate mit verzoegerter wirkung, verfahren zu deren herstellung sowie entsprechende mittel zur human- bzw. veterinaermedizinischen anwendung
JPS6218742A (ja) * 1985-07-18 1987-01-27 Sony Corp ヒ−トシンクの製造方法
NZ217844A (en) * 1985-10-11 1989-10-27 Sumitomo Pharma A sustained release pharmaceutical composition containing silicone elastomer and an albumin
AU586306B2 (en) * 1985-12-16 1989-07-06 Ethicon Inc. Method for inhibiting post-surgical adhesion formation by the topical administration of tissue plasminogen activator

Also Published As

Publication number Publication date
DK675389A (da) 1990-02-28
DE3883645T2 (de) 1994-02-03
DK675389D0 (da) 1989-12-29
PH26527A (en) 1992-08-07
KR890701124A (ko) 1989-12-19
FI896359A0 (fi) 1989-12-29
DE3883645D1 (de) 1993-10-07
DK175597B1 (da) 2004-12-13
IE65658B1 (en) 1995-11-15
NO301748B1 (no) 1997-12-08
EP0297860B1 (en) 1993-09-01
JP2756131B2 (ja) 1998-05-25
AU1998588A (en) 1989-01-30
FI103868B1 (fi) 1999-10-15
EP0297860A1 (en) 1989-01-04
WO1989000049A1 (en) 1989-01-12
IL102625A0 (en) 1993-01-14
FI103868B (fi) 1999-10-15
NZ225260A (en) 1991-03-26
PT87886B (pt) 1993-09-30
PT87886A (pt) 1989-06-30
AU621305B2 (en) 1992-03-12
NO895338D0 (no) 1989-12-29
KR0131330B1 (ko) 1998-04-17
IE882023L (en) 1989-01-01
IL86933A (en) 1993-07-08
JPH04502753A (ja) 1992-05-21

Similar Documents

Publication Publication Date Title
NO884807L (no) Fremgangsmaate og anordning for utbedring av foringsroer.
NO170394C (no) Fremgangsmaate og system for behandling av dispersjoner avborkaks og lignende
DK10289A (da) Fremgangsmaade og praeparater til forebyggelse af ulcus
NO880443L (no) N-heterosyklisk-n-(4-piperidyl)-amider og farmasoeytiske preparater og fremgangsmaater for bruk av slike forbindelser.
NO881322D0 (no) Fremgangsmaate og anlegg for behandling av returnert boreslam.
NO895338L (no) Fremgangsmaate og terapeutiske preparater for forhindring av fibrinavsetning eller adhesjoner.
NO893142D0 (no) Fremgangsmaate for preservering av oftalmologiske opploesninger og sammensetninger for formaalet.
NO167664C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive castanosperminestere og glycosider.
NO882462D0 (no) Fremstilling og bruk av fenolderivater.
EP0223254A3 (en) Preparations for the treatment and prevention of epithelial destruction
NO901272D0 (no) Sammensetning og fremgangsmaate for fjerning av sulfider.
NO884324D0 (no) Fremgangsmaate til fremstilling av reninhemmende peptider og deres anvendelse.
NO881713L (no) Fremgangsmaate for fremstilling av di-t-butylfenyl-alkyl og benzylethere.
NO891630D0 (no) Fremgangsmaate og anordning for fremstilling av diafragmer.
NO864728L (no) Fremgangsmaate og apparat for kryopresipitering av blodplasma.
NO883927D0 (no) Staal og anvendelse av dette.
NO882336D0 (no) Fremgangsmaate for fremstilling av 5-metoksyalkylammoniun-tetrahydrofuraner og tetrahydrotiofener.
NO891986L (no) Fremgangsmaate for fremstilling av difenyl-sulfider, difenyl-sulfoksyder og difenylsulfoner.
NO884635D0 (no) Fremgangsmaate for behandling av most.
DK670588D0 (da) Farmaceutisk praeparat til behandling af phlebektasi og fremgangsmaade til fremstilling af praeparatet
NO901421D0 (no) Intranasal administrering av fysostigmin og arecolin.
ZA884739B (en) Method and therapeutic compositions for the prevention of fibrin deposition or adhesions
NO912279D0 (no) Fremgangsmaate for fremstilling og anvendelse av eksplosjonssikre 1-dimetylamino-3-dimetylimino-2-arylprop-1-en-salter.
NO165155C (no) Framgangsmaate for bygging og demontering av bygningsdeler.
NO872673L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kinoksalindioner og kinolindioner.

Legal Events

Date Code Title Description
MK1K Patent expired